You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 15, 2021

Hemp Now Legally Permitted for Use in Cosmetics in Thailand

Following the recent delisting of almost all parts of the hemp plant from Thailand’s list of prohibited narcotics (see here for further details), the Ministry of Public Health has issued a notification allowing hemp to be used in cosmetics. Prior to this development, this use of hemp (whether from natural or synthetic sources) was not allowed, as it fell under the definition of narcotics under the Notification Re: Ingredients Not Allowed for Use in Cosmetics B.E. 2559 (2016).

Under the Ministerial Notification Re: Use of Hemp in Cosmetics B.E. 2564 (2021), which was published in the Government Gazette on January 11, 2021, domestic manufacturers are now allowed to produce cosmetics containing hemp seed oil or hemp seed extract, provided the cosmetics do not have a THC level exceeding 0.2% by weight.

To register such products with the Thai FDA, applicants must submit a certificate of analysis, safety data sheet, and label for the agency’s evaluation. The timeline for approval of the registration (notification) of a cosmetic containing hemp seed oil or hemp seed extract is three business days. The applicant (i.e., manufacturer or toll manufacturer) must declare the amount of hemp seed extract or hemp seed oil used in the cosmetic in their notification application. Cosmetics must not use a name for the product that evokes an association with hemp flowers or narcotics, and the name of the product must be within the scope of cosmetics. For example, names containing “inflorescence,” “flower,” “CBD,” “THC” or similar will not be allowed.

It should also be noted that Thailand does not yet allow the importation of cosmetics containing hemp seeds or hemp seed extract, and this regulation only applies to domestically produced hemp products—a business currently restricted to individuals or companies with Thai nationality.

For more details on this development, or on any aspect of hemp and cannabis regulations in Thailand, please contact Tilleke & Gibbins at [email protected].

RELATED INSIGHTS​ 

May 3, 2011
In Thailand, the importation, manufacture, and sale of medicine is governed by the Medicine Act B.E. 2510 (1967). The Act also stipulates the requirements/procedures to apply for a license to import, manufacture, or sell medicine and the duties and obligations with which such license holder must comply. This article provides an overview of the requirements.
May 3, 2011
Written in a Q&A format, this chapter provides a comprehensive overview of the issues faced by life sciences companies in Thailand. Topics covered include the regulatory framework, manufacturing of medicinal products, clinical trials, marketing restrictions, packaging and labeling requirements, intellectual property issues, and product liability.
May 3, 2011
Before being marketed in Thailand, a wide variety of products must be registered at the Thai Food and Drug Administration (FDA). These products range from food, food supplements, beverages and medical devices to animal health products, cosmetics, hazardous substances, and all types of pharmaceuticals. Due to the large number of product applications that are filed at the Thai FDA and the stringency of registration requirements, registration timelines—particularly for pharmaceutical products—can be very long.
April 30, 2011
In recent years, Thailand has seen an increasing number of pharmaceutical patent litigations, launched by drug originators to combat infringing generic products in the market. This article looks at the forces underlying this trend and recommends several legal options to allow drug originators to defend their products against low-price infringing generics.